Amalgamated Bank Icosavax, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
SELL
$5.95 - $15.79 $1,380 - $3,663
-232 Reduced 10.04%
2,078 $33,000
Q1 2023

May 02, 2023
SELL
$5.62 - $11.51 $2,899 - $5,939
-516 Reduced 18.26%
2,310 $13,000
Q2 2022

Aug 15, 2022
BUY
$5.7 - $10.33 $1,442 - $2,613
253 Added 9.83%
2,826 $16,000
Q1 2022

Jun 30, 2022
BUY
$4.41 - $22.5 $11,346 - $57,892
2,573 New
2,573 $18,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email